Colorado Capitol Watch

Login

Welcome Visitor

 
Forgot password?
----------
Subscribe for Current Session

My CCW Tools

Look Up Bills

Look Up Legislators

border
border
Legislative Year: 2018 Change
  •  
  •  
hdr_right_bottom

Bill Tracker

based on: Profile

 
 
Loading... Please Wait

This report is based on Sample Data.
Subscribed users can select the bills and legislators to show on this report.

Subscribe Here
You have 34 bills in your selected Profile


Bill: HB18-1003
Title: Opioid Misuse Prevention
Position
Hearing Time
Hearing Room
CCW Summary

Concerning measures to prevent opioid misuse in Colorado.

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (05/21/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsB. Pettersen (D)
House CommitteePublic Health Care and Human Services
Hearing Date
Fiscal NotesFiscal Notes (04/27/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/27/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

Opioid and Other Substance Use Disorders Interim Study
Committee. Section 1 of the bill establishes in statute the opioid and
other substance use disorders study committee, consisting of 5 senators
and 5 representatives from the general assembly, to:
  • Study data and statistics on the scope of the substance use
disorder problem in Colorado;
  • Study current prevention, intervention, harm reduction,
treatment, and recovery resources available to Coloradans,

as well as public and private insurance coverage and other
sources of support for treatment and recovery resources;
  • Review the availability of medication-assisted treatment
and the ability of pharmacists to prescribe those
medications;
  • Examine measures that other states and countries use to
address substance use disorders;
  • Identify the gaps in prevention, intervention, harm
reduction, treatment, and recovery resources available to
Coloradans and hurdles to accessing those resources; and
  • Identify possible legislative options to address gaps and
hurdles to accessing prevention, intervention, harm
reduction, treatment, and recovery resources.
The committee is authorized to meet 6 times in a calendar year and
may report up to 6 legislative measures to the legislative council, which
bills are exempt from bill limitations and introduction deadlines. The
committee is repealed on July 1, 2020.
Section 2 specifies school-based health care centers may apply for
grants from the school-based health center grant program to expand
behavioral health services to include treatment for opioid and other
substance use disorders.
Section 3 directs the department of health care policy and
financing, starting July 1, 2018, to award grants to organizations to
operate a substance abuse screening, brief intervention, and referral
program.
Section 4 directs the center for research into substance use
disorder prevention, treatment, and recovery to develop and implement
continuing medical education activities to help prescribers of pain
medication to safely and effectively manage patients with chronic pain,
and when appropriate, prescribe opioids. Sections 2 through 4 also direct
the general assembly to appropriate money to implement those sections.

House SponsorsB. Pettersen (D)
Senate SponsorsK. Priola (R)
C. Jahn (D)
House CommitteePublic Health Care and Human Services
Senate CommitteeState, Veterans, and Military Affairs
StatusGovernor Signed (05/21/2018)
LobbyistsLobbyists
Category

Bill: HB18-1007
Title: Substance Use Disorder Payment And Coverage
Position
Hearing Time
Hearing Room
CCW Summary

Concerning payment issues related to substance use disorders.

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (05/21/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsJ. Singer (D)
C. Kennedy (D)
House CommitteePublic Health Care and Human Services
Hearing Date
Fiscal NotesFiscal Notes (04/24/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/24/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

Opioid and Other Substance Use Disorders Interim Study
Committee. The bill requires all individual and group health benefit
plans to provide coverage without prior authorization for a five-day
supply of buprenorphine for a first request within a 12-month period.
Additionally, all individual and group health benefit plans that
cover physical therapy, acupuncture, or chiropractic services shall not

subject those services to dollar limits, deductibles, copayments, or
coinsurance provisions that are less favorable than those applicable to
primary care services under the plan if the covered person has a diagnosis
of chronic pain and has or has had a substance use disorder diagnosis.
The bill prohibits carriers from taking adverse action against a
provider or from providing financial incentives or disincentives to a
provider based solely on a patient satisfaction survey relating to the
patient's satisfaction with pain treatment.
The bill clarifies that an urgent prior authorization request to a
carrier includes a request for authorization of medication-assisted
treatment for substance use disorders.
The bill permits a pharmacist who has entered into a collaborative
pharmacy practice agreement with one or more physicians to administer
injectable medication-assisted treatment for substance use disorders and
receive an enhanced dispensing fee for the administration.
The bill prohibits carriers from requiring a covered person to
undergo step therapy using a prescription drug or drugs that include an
opioid before covering a non-opioid prescription drug recommended by
the covered person's provider.
The bill requires the Colorado medical assistance program to
authorize reimbursement for a ready-to-use version of intranasal naloxone
hydrochloride without prior authorization.
The bill prohibits the requirement that a recipient of medical
assistance undergo a step-therapy protocol using a prescription drug
containing an opioid prior to authorizing reimbursement for a non-opioid
prescription drug recommended by the person's health care provider.
The bill permits a pharmacist who has entered into a collaborative
pharmacy practice agreement with one or more physicians to administer
injectable medication-assisted treatment for substance use disorders and
receive an enhanced dispensing fee under the Colorado medical
assistance program for the administration.
The bill requires the department of health care policy and
financing and the office of behavioral health in the department of human
services to establish rules that standardize utilization management
authority timelines for the non-pharmaceutical components of
medication-assisted treatment for substance use disorders.

House SponsorsJ. Singer (D)
C. Kennedy (D)
Senate SponsorsC. Jahn (D)
K. Lambert (R)
House CommitteePublic Health Care and Human Services
Senate CommitteeState, Veterans, and Military Affairs
StatusGovernor Signed (05/21/2018)
LobbyistsLobbyists
Category

Bill: HB18-1009
Title: Diabetes Drug Pricing Transparency Act 2018
Position
Hearing Time
Hearing Room
CCW Summary

Concerning transparency in diabetes prescription drugs pricing.

Bill Subject- Health Care & Health Insurance
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (05/02/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsD. Roberts (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (04/13/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/13/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill creates the Diabetes Drug Pricing Transparency Act of
2018. The state board of health is responsible for implementing the act.
Drug manufacturers and pharmacy benefit managers must submit annual
reports to the state board regarding drugs used to treat diabetes that are
subject to price increases of certain percentages. The state board analyzes
the submitted information and publishes a report. The state board may

impose penalties on drug manufacturers or pharmacy benefit managers
who do not comply with reporting requirements. Nonprofit organizations
advocating for patients with diabetes or funding diabetes medical research
that receive contributions from certain diabetes drug manufacturers must
annually report those contributions.

House SponsorsD. Roberts (D)
Senate SponsorsK. Donovan (D)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeState, Veterans, and Military Affairs
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (05/02/2018)
LobbyistsLobbyists
Category

Bill: HB18-1044
Title: Colorado Children's Trust Fund Act
Position
Hearing Time
Hearing Room
CCW Summary

Concerning the 'Colorado Children's Trust Fund Act'.

Bill Subject- Children & Domestic Matters
- Human Services
- Public Health
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (02/26/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsT. Kraft-Tharp (D)
House CommitteePublic Health Care and Human Services
Hearing Date
Fiscal NotesFiscal Notes (02/20/2018)
Hearing Date
Fiscal NotesFiscal Notes (02/20/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill amends current statutory language in the Colorado
Children's Trust Fund Act to place a greater priority on preventing child
maltreatment fatalities and continuing to prevent child maltreatment. This
includes reducing the occurrence of prenatal drug exposure and drug
endangerment and reducing the occurrence of other adverse childhood
experiences.
The current membership of the Colorado children's trust fund
board (board) is increased from 9 members to 21 members, to reflect a

broader approach to child maltreatment prevention issues.
Duties and powers of the board are expanded to include:
  • Advising and making recommendations to the governor,
state agencies, and other entities concerning child
maltreatment prevention;
  • Developing strategies and monitoring efforts to decrease
incidences of child maltreatment, child maltreatment
fatalities, and other adverse childhood experiences; and
  • Monitoring and implementing, as appropriate, the ongoing
development and implementation of programs and factors
that affect work in the area of childhood maltreatment.
The bill expands the accepted uses for grants from the Colorado
children's trust fund to include programs working to reduce the incidence
of child maltreatment fatalities, child maltreatment, and other adverse
childhood experiences.
The repeal date for the act is extended from July 1, 2022, to July
1, 2023.

House SponsorsT. Kraft-Tharp (D)
Senate SponsorsK. Priola (R)
House CommitteePublic Health Care and Human Services
Senate CommitteeState, Veterans, and Military Affairs
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (02/26/2018)
LobbyistsLobbyists
Category

Bill: HB18-1082
Title: A Woman's Right To Accurate Health Care Information
Position
Hearing Time
Hearing Room
CCW Summary

Concerning the creation of the 'Women's Reproductive Information Guarantee for Health and Transparency (RIGHT) Act'.

Bill Subject- Health Care & Health Insurance
StatusHouse Committee on Health, Insurance, & Environment Postpone Indefinitely (02/22/2018)
Senate Committee
House SponsorsL. Saine (R)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (02/22/2018)
Hearing Date
Fiscal NotesFiscal Notes (02/22/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill ensures that women are fully and accurately informed
about their personal medical conditions regarding their pregnancies and
health care options. Current medical procedures already use ultrasound
technology to provide information regarding the gestational age of a child
in utero. The bill ensures that a woman has the opportunity to see or

forego seeing her ultrasound. The bill gives the woman a choice between
an abdominal or vaginal ultrasound. The bill allows a woman the
opportunity to find a provider of ultrasound technology that will provide
the service free of charge. The bill requires that a woman be given full
and accurate information regarding her abortion. The bill describes the
information that the physician performing the abortion provides to the
woman and gives the woman an opportunity to sign or refuse to sign a
receipt of information. The bill requires the abortion provider to provide
certain information to the woman at least 24 hours prior to performing an
abortion.
The bill creates a civil right of action for noncompliance with the
requirements, making a physician's noncompliance with the requirements
unprofessional conduct and making a violation of the requirements a
crime.

House SponsorsL. Saine (R)
Senate SponsorsV. Marble (R)
House CommitteeHealth, Insurance, & Environment
Senate Committee
StatusHouse Committee on Health, Insurance, & Environment Postpone Indefinitely (02/22/2018)
LobbyistsLobbyists
Category

Bill: HB18-1097
Title: Patient Choice Of Pharmacy
Position
Hearing Time
Hearing Room
CCW Summary Concerning the ability of a person eligible for prescription drug benefits to choose the pharmacy at which to fill a prescription drug order.

 

Bill Subject- Health Care & Health Insurance
StatusSenate Committee on Business, Labor, & Technology Postpone Indefinitely (03/19/2018)
Senate CommitteeBusiness, Labor and Technology
House SponsorsJ. Danielson (D)
M. Catlin (R)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (02/14/2018)
Hearing Date
Fiscal NotesFiscal Notes (02/14/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill prohibits a carrier that offers or issues a health benefit
plan that covers pharmaceutical services, including prescription drug
coverage, or a pharmacy benefit management firm managing those
benefits for a carrier, from:
  • Limiting or restricting a covered person's ability to select a

pharmacy or pharmacist of the covered person's choice if
certain conditions are met;
  • Imposing a copayment, fee, or other cost-sharing
requirement for selecting a pharmacy of the covered
person's choosing;
  • Imposing other conditions on a covered person, pharmacist,
or pharmacy that limit or restrict a covered person's ability
to use a pharmacy of the covered person's choosing; or
  • Denying a pharmacy or pharmacist the right to participate
in any of its pharmacy network contracts in this state or as
a contracting provider in this state if the pharmacy or
pharmacist has a valid license in Colorado and the
pharmacy or pharmacist agrees to specified conditions.

House SponsorsJ. Danielson (D)
M. Catlin (R)
Senate SponsorsN. Todd (D)
D. Coram (R)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeBusiness, Labor and Technology
StatusSenate Committee on Business, Labor, & Technology Postpone Indefinitely (03/19/2018)
LobbyistsLobbyists
Category

Bill: HB18-1114
Title: Require License Practice Genetic Counseling
Position
Hearing Time
Hearing Room
CCW Summary

Concerning the regulation of genetic counselors.

Bill Subject- Business & Economic Development
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (04/24/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsJ. Buckner (D)
J. Ginal (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (03/07/2018)
Hearing Date
Fiscal NotesFiscal Notes (03/07/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill enacts the Genetic Counselor Licensure Act. On and
after June 1, 2019, a person cannot practice genetic counseling without
being licensed by the director of the division of professions and
occupations in the department of regulatory agencies. To be licensed, a
person must have graduated with an appropriate genetic counseling
degree and have been certified by a national body, except that the
director:
  • May issue a provisional license to a candidate for

certification pursuant to requirements established by rule;
and
  • Shall license a genetic counselor who graduated from a
Colorado genetic counseling training program, has at least
15 years of experience, and provides at least 3 letters of
recommendation.
The bill gives title protection to genetic counselors and standard
licensing, rule-making, and disciplinary powers to the director. Genetic
counselors must have insurance unless the director, by rule, finds that
insurance is not reasonably available. The bill repeals the act on
September 1, 2022. Genetic counselors are subject to the mandatory
disclosures of the Michael Skolnik Medical Transparency Act of 2010.

House SponsorsJ. Buckner (D)
J. Ginal (D)
Senate SponsorsN. Todd (D)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeState, Veterans, and Military Affairs
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (04/24/2018)
LobbyistsLobbyists
Category

Bill: HB18-1148
Title: Stage Four Advanced Metastatic Cancer Step Therapy
Position
Hearing Time
Hearing Room
CCW Summary

Concerning the prohibition against a carrier requiring step therapy for covered persons with stage four advanced metastatic cancer.

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (04/09/2018)
Senate CommitteeHealth and Human Services
House SponsorsD. Michaelson Jenet (D)
House CommitteePublic Health Care and Human Services
Hearing Date
Fiscal NotesFiscal Notes (02/16/2018)
Hearing Date
Fiscal NotesFiscal Notes (02/16/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill prohibits a carrier that issues a health benefit plan that
covers treatment for stage four advanced metastatic cancer from requiring
a cancer patient to undergo step therapy prior to receiving a drug
approved by the United States food and drug administration if use of the
approved drug is consistent with best practices for treatment of the

cancer.

House SponsorsD. Michaelson Jenet (D)
Senate SponsorsL. Crowder (R)
House CommitteePublic Health Care and Human Services
Senate CommitteeHealth and Human Services
StatusGovernor Signed (04/09/2018)
LobbyistsLobbyists
Category

Bill: HB18-1155
Title: Sunset Continue Physical Therapy Board Functions
Position
Hearing Time
Hearing Room
CCW Summary

Concerning the continuation of the physical therapy board, and, in connection therewith, implementing the recommendations contained in the 2017 sunset review and report by the department of regulatory agencies.

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (05/29/2018)
Senate CommitteeHealth and Human Services
House SponsorsL. Liston (R)
J. Singer (D)
House CommitteePublic Health Care and Human Services
Hearing Date
Fiscal NotesFiscal Notes (04/11/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/11/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

Sunset Process - House Public Health Care and Human
Services Committee. The bill implements the recommendations of the
department of regulatory agencies in its sunset review and report

concerning the Physical Therapy Practice Act as follows:
  • Extends the licensing of physical therapists and the
certification of physical therapist assistants until 2027
(sections 1 through 3);
  • Clarifies that a physical therapist may make physical
therapy diagnoses (sections 5 and 7);
  • Clarifies that a physical therapist's scope of practice
includes the direct supervision of unlicensed physical
therapists (section 8); and
  • Adds as grounds for disciplinary action the failure to
supervise physical therapist assistants; and the failure to
report an adverse action, the surrender of a license, or other
discipline taken in another jurisdiction (section 10).
In addition, the bill:
  • Allows a physical therapist assistant to perform
noninvasive wound debridement under the supervision of
a physical therapist (sections 11 and 13);
  • Repeals some of elements of the continuing professional
competency program for physical therapists (section 9) and
subjects physical therapist assistants to a continuing
professional competency program (section 12);
  • Replaces a physical therapist member of the physical
therapy board with a physical therapist assistant member
(section 6); and
  • Removes physical therapists practicing in Colorado
pursuant to the Interstate Physical Therapy Licensure
Compact Act from the Michael Skolnik Medical
Transparency Act of 2010 (section 14).

House SponsorsL. Liston (R)
J. Singer (D)
Senate SponsorsB. Martinez Humenik (R)
House CommitteePublic Health Care and Human Services
Senate CommitteeHealth and Human Services
StatusGovernor Signed (05/29/2018)
LobbyistsLobbyists
Category

Bill: HB18-1179
Title: Prohibit Price Gouging On Prescription Drugs
Position
Hearing Time
Hearing Room
CCW Summary

Concerning a prohibition against price gouging on certain prescription drugs.

Bill Subject- Health Care & Health Insurance
StatusHouse Second Reading Laid Over to 08/31/2018 - No Amendments (05/02/2018)
Senate Committee
House SponsorsJ. Salazar (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (02/16/2018)
Hearing Date
Fiscal NotesFiscal Notes (02/16/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill:
  • Prohibits a pharmaceutical manufacturer or wholesaler
from price gouging on sales of essential off-patent or
generic drugs;
  • Makes the practice of price gouging a deceptive trade
practice under the Colorado Consumer Protection Act;

and
  • Requires the state board of pharmacy and the executive
director of the department of health care policy and
financing to report suspected price gouging to the attorney
general. The attorney general is authorized to seek
subpoenas and file lawsuits with the appropriate district
courts.

House SponsorsJ. Salazar (D)
Senate Sponsors
House CommitteeHealth, Insurance, & Environment
Senate Committee
StatusHouse Second Reading Laid Over to 08/31/2018 - No Amendments (05/02/2018)
LobbyistsLobbyists
Category

Bill: HB18-1187
Title: Food And Drug Administration Cannabidiol Drug Use
Position
Hearing Time
Hearing Room
CCW Summary Concerning the lawful use of a prescription drug that contains cannabidiol that is approved by the United States food and drug administration.

 

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (06/04/2018)
Senate CommitteeBusiness, Labor and Technology
House SponsorsJ. Buckner (D)
L. Landgraf (R)
House CommitteePublic Health Care and Human Services
Hearing Date
Fiscal NotesFiscal Notes (04/12/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/12/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill makes it clear that if the United States food and drug
administration approves a prescription medicine that contains
cannabidiol, thereafter, prescribing, dispensing, transporting, possessing,
and using that prescription drug is legal in Colorado.

House SponsorsJ. Buckner (D)
L. Landgraf (R)
Senate SponsorsD. Moreno (D)
J. Cooke (R)
House CommitteePublic Health Care and Human Services
Senate CommitteeBusiness, Labor and Technology
StatusGovernor Signed (06/04/2018)
LobbyistsLobbyists
Category

Bill: HB18-1207
Title: Hospital Financial Transparency Measures
Position
Hearing Time
Hearing Room
CCW Summary

Concerning hospital transparency measures required to analyze the efficacy of hospital delivery system reform incentive payments.

Bill Subject- Health Care & Health Insurance
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (04/30/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsB. Rankin (R)
C. Kennedy (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (06/08/2018)
Hearing Date
Fiscal NotesFiscal Notes (06/08/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill requires the department of health care policy and
financing (department), in consultation with the Colorado healthcare
affordability and sustainability enterprise board, to develop and prepare
an annual report detailing uncompensated hospital costs and the different
categories of expenditures made by general hospitals in the state (hospital

expenditure report). In compiling the hospital expenditure report, the
department shall use publicly available data sources whenever possible.
Each general hospital in the state is required to make available to the
department certain information, including:
  • Hospital cost reports submitted to the federal centers for
medicare and medicaid services;
  • Annual audited financial statements; except that, if a
hospital is part of a consolidated or combined group, the
hospital may submit a consolidated or combined financial
statement if the group's statement separately identifies the
information for each of the group's licensed hospitals;
  • Utilization and staffing information and standard units of
measure; and
  • Information accessed through a secure, online data
collection and reporting system that provides a central
location for the collection and analysis of hospital
utilization and financial data.
The hospital expenditure report must include, but not be limited to:
  • A description of the methods of analysis and definitions of
report components by payer group;
  • Uncompensated care costs by payer group; and
  • The percentage that different categories of expenses
contribute to overall expenses of hospitals.
The department is required to submit the hospital expenditure
report to the governor, specified committees of the general assembly, and
the medical services board in the department. The department is also
directed to post the hospital expenditure report on the department's
website.

House SponsorsB. Rankin (R)
C. Kennedy (D)
Senate SponsorsD. Moreno (D)
J. Smallwood (R)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeState, Veterans, and Military Affairs
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (04/30/2018)
LobbyistsLobbyists
Category

Bill: HB18-1225
Title: Protect Human Life At Conception
Position
Hearing Time
Hearing Room
CCW Summary

Concerning the protection of human life beginning at conception.

Bill Subject- Crimes, Corrections, & Enforcement
- Health Care & Health Insurance
StatusHouse Committee on Health, Insurance, & Environment Postpone Indefinitely (02/22/2018)
Senate Committee
House SponsorsS. Humphrey (R)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (05/21/2018)
Hearing Date
Fiscal NotesFiscal Notes (05/21/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill prohibits terminating the life of an unborn child and
makes a violation a class 1 felony. The following are exceptions to the
prohibition:
  • A licensed physician performs a medical procedure
designed or intended to prevent the death of a pregnant
mother, if the physician makes reasonable medical efforts

under the circumstances to preserve both the life of the
mother and the life of her unborn child in a manner
consistent with conventional medical practice; and
  • A licensed physician provides medical treatment, including
chemotherapy and the removal of an ectopic pregnancy, to
the mother that results in the accidental or unintentional
injury to or death of the unborn child.
The pregnant mother upon whom termination of the life of an
unborn child is performed or attempted is not subject to a criminal
penalty. The sale and use of contraception is not prohibited by the bill. A
conviction related to the prohibition of the termination of the life of an
unborn child constitutes unprofessional conduct for purposes of physician
licensing.

House SponsorsS. Humphrey (R)
Senate SponsorsK. Lundberg (R)
House CommitteeHealth, Insurance, & Environment
Senate Committee
StatusHouse Committee on Health, Insurance, & Environment Postpone Indefinitely (02/22/2018)
LobbyistsLobbyists
Category

Bill: HB18-1255
Title: Childhood Cancer Awareness Special License Plate
Position
Hearing Time
Hearing Room
CCW Summary
Bill Subject- Transportation & Motor Vehicles
StatusGovernor Signed (05/22/2018)
Senate CommitteeFinance
House SponsorsC. Duran (D)
T. Carver (R)
House CommitteeTransportation & Energy
Hearing Date
Fiscal NotesFiscal Notes (02/28/2018)
Hearing Date
Fiscal NotesFiscal Notes (02/28/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill creates the childhood cancer awareness license plate. A
person becomes eligible to use the plate by providing a certificate
confirming that the person has made a donation to an organization chosen
by the department of revenue based on the organization's assistance to
children with cancer.
In addition to the standard motor vehicle fees, the plate requires 2

one-time fees of $25. One of the fees is credited to the highway users tax
fund and the other to the licensing services cash fund.

House SponsorsC. Duran (D)
T. Carver (R)
Senate SponsorsJ. Kefalas (D)
J. Cooke (R)
House CommitteeTransportation & Energy
Senate CommitteeFinance
StatusGovernor Signed (05/22/2018)
LobbyistsLobbyists
Category

Bill: HB18-1260
Title: Prescription Drug Price Transparency
Position
Hearing Time
Hearing Room
CCW Summary

Concerning prescription drug price transparency.

Bill Subject- Health Care & Health Insurance
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (04/30/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsJ. Ginal (D)
D. Jackson (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (03/14/2018)
Hearing Date
Fiscal NotesFiscal Notes (03/14/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill enacts the Colorado Prescription Drug Price
Transparency Act of 2018, which requires:
  • Health insurers, starting in 2019, to submit to the
commissioner of insurance (commissioner), as part of the
health care cost reporting requirement, information
regarding prescription drugs covered under their health
insurance plans that were dispensed in the preceding
calendar year;

  • Prescription drug manufacturers, on or after July 1, 2018,
to notify state purchasers, health insurers, and pharmacy
benefit management firms when the manufacturer increases
the price of certain prescription drugs by more than 10% or
when the manufacturer introduces a new specialty drug in
the commercial market; and
  • Prescription drug manufacturers, within 15 days after the
end of each calendar quarter that starts on or after July 1,
2018, to provide specified information to the commissioner
regarding the drugs about which manufacturers are
required to notify purchasers of a drug price increase or
new specialty drug on the market.
The commissioner is required to post the information received
from prescription drug manufacturers on the division of insurance
website. Additionally, the commissioner, or a disinterested third-party
contractor, is to analyze the data submitted by health insurers and
prescription drug manufacturers and other relevant information to
determine the effect of prescription drug costs on health insurance
premiums. The commissioner is to publish a report each year, submit the
report to specified legislative committees, and present the report during
annual State Measurement for Accountable, Responsive, and
Transparent (SMART) Government Act hearings. The commissioner is
authorized to adopt rules as necessary to implement the requirements of
the act.
A prescription drug manufacturer that fails to notify purchasers or
fails to report required data to the commissioner is subject to discipline
by the state board of pharmacy, including a penalty of $1,000 per day for
each day the manufacturer fails to comply with the notice or reporting
requirements. The commissioner is to report manufacturer violations to
the state board of pharmacy.

House SponsorsJ. Ginal (D)
D. Jackson (D)
Senate SponsorsD. Moreno (D)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeState, Veterans, and Military Affairs
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (04/30/2018)
LobbyistsLobbyists
Category

Bill: HB18-1279
Title: Electronic Prescribing Controlled Substances
Position
Hearing Time
Hearing Room
CCW Summary Concerning a requirement that certain practitioners prescribe controlled substances electronically.

 

Bill Subject- Health Care & Health Insurance
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (04/25/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsD. Esgar (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (04/05/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/05/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill requires podiatrists, dentists, physicians, physician
assistants, advanced practice nurses, and optometrists, starting July 1,
2020, and practitioners serving rural communities or in a solo practice,
starting July 1, 2021, to prescribe controlled substances only via a
prescription that is electronically transmitted to a pharmacy unless a
specified exception applies. Prescribers are required to indicate on license

renewal questionnaires whether they have complied with the electronic
prescribing requirement. Pharmacists need not verify the applicability of
an exception to electronic prescribing when they receive an order for a
controlled substance in writing, orally, or via facsimile transmission and
may fill the order if otherwise valid under the law.

House SponsorsD. Esgar (D)
Senate SponsorsK. Priola (R)
D. Moreno (D)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeState, Veterans, and Military Affairs
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (04/25/2018)
LobbyistsLobbyists
Category

Bill: HB18-1282
Title: Health Care Provider Unique Identification Per Site Or Service
Position
Hearing Time
Hearing Room
CCW Summary

Concerning a requirement that a health care provider include certain identifying information on all claims for reimbursement for health care services.

Bill Subject- Health Care & Health Insurance
- Insurance
- Public Health
StatusGovernor Signed (04/25/2018)
Senate CommitteeHealth and Human Services
House SponsorsL. Sias (R)
S. Lontine (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (03/15/2018)
Hearing Date
Fiscal NotesFiscal Notes (03/15/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

Section 2 of the bill requires an off-campus location of a hospital
to apply for, obtain, and use on claims for reimbursement for health care
services provided at the off-campus location a unique national provider
identifier, commonly referred to as NPI. The off-campus location's NPI
must be used on all claims related to health care services provided at that

location, regardless of whether the claim is filed through the hospital's
central billing or claims department or through a health care
clearinghouse.
Section 3 requires all medicaid providers that are entities to obtain
and use a unique NPI for each site at which they deliver services and for
each provider type that the department of health care policy and financing
has specified. Entity medicaid providers must use on all claims the unique
NPI that identifies both the site where the services were provided and the
provider type rendering the services, regardless of whether the claim is
filed through the entity's central billing or claims department or through
a health care clearinghouse.

House SponsorsL. Sias (R)
S. Lontine (D)
Senate SponsorsJ. Kefalas (D)
J. Smallwood (R)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeHealth and Human Services
StatusGovernor Signed (04/25/2018)
LobbyistsLobbyists
Category

Bill: HB18-1284
Title: Disclosure Of Prescription Costs At Pharmacies
Position
Hearing Time
Hearing Room
CCW Summary

Concerning the cost of prescription drugs purchased at a pharmacy.

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (04/30/2018)
Senate CommitteeHealth and Human Services
House SponsorsJ. Buckner (D)
J. Wilson (R)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (03/28/2018)
Hearing Date
Fiscal NotesFiscal Notes (03/28/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill enacts the Patient Drug Costs Savings Act (act). The act
prohibits a carrier that has a contract with a pharmacy or pharmacist, or
a pharmacy benefit management firm acting on behalf of a carrier, from:
  • Prohibiting a pharmacy or pharmacist from, or penalizing
a pharmacy or pharmacist for, providing a covered person
information on the amount of the covered person's cost

share for the covered person's prescription drug and the
clinical efficacy of any more affordable alternative drugs
that are therapeutically equivalent; or
  • Requiring a pharmacy to charge or collect a copayment
from a covered person that exceeds the total submitted
charges by the network pharmacy.
The act requires the commissioner of insurance to act when the
commissioner determines that a carrier or pharmacy benefit management
firm has not complied with the above prohibitions.

House SponsorsJ. Buckner (D)
J. Wilson (R)
Senate SponsorsJ. Kefalas (D)
B. Martinez Humenik (R)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeHealth and Human Services
StatusGovernor Signed (04/30/2018)
LobbyistsLobbyists
Category

Bill: HB18-1307
Title: Limit Access To Products With Dextromethorphan
Position
Hearing Time
Hearing Room
CCW Summary

Concerning restricting the availability to children of products that contain dextromethorphan.

Bill Subject- Children & Domestic Matters
- Crimes, Corrections, & Enforcement
- Public Health
StatusGovernor Signed (05/11/2018)
Senate CommitteeJudiciary
House SponsorsJ. Singer (D)
P. Lee (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (06/25/2018)
Hearing Date
Fiscal NotesFiscal Notes (06/25/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill states that it is unlawful for a seller, retailer, or vendor to
knowingly or willfully dispense, sell, or distribute a finished drug product
containing any quantity of dextromethorphan to a person less than 18
years of age. A seller, retailer, or vendor making a retail sale of a finished
drug product containing any quantity of dextromethorphan must require
and obtain proof of age from the purchaser before completing the sale

unless the seller, retailer, or vendor reasonably presumes from the
purchaser's outward appearance that the purchaser is at least 25 years of
age.
A seller, retailer, or vendor who violates the prohibition or who
fails to obtain proof of age when required to do so commits an
unclassified petty offense and, upon conviction thereof, shall be punished
as follows:
  • For a first offense, the court shall warn the seller, retailer,
or vendor in writing; and
  • For a second or subsequent offense, the seller, retailer, or
vendor shall pay a fine of not more than $200.
The prohibition does not apply to a medication containing
dextromethorphan, which medication is sold pursuant to a valid
prescription. It is an affirmative defense if the seller, retailer, or vendor
is an employer and trains its employees concerning the bill's restrictions
on the distribution of medications containing dextromethorphan.

House SponsorsJ. Singer (D)
P. Lee (D)
Senate SponsorsR. Gardner (R)
J. Cooke (R)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeJudiciary
StatusGovernor Signed (05/11/2018)
LobbyistsLobbyists
Category

Bill: HB18-1313
Title: Pharmacists To Serve As Practitioners
Position
Hearing Time
Hearing Room
CCW Summary

Concerning the allowance of a pharmacist to serve as a practitioner under certain circumstances.

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (06/06/2018)
Senate CommitteeHealth and Human Services
House SponsorsJ. Ginal (D)
J. Becker (R)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (04/06/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/06/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill clarifies that a licensed and qualified pharmacist may
serve as a practitioner and prescribe over-the-counter medication under
the Colorado Medical Assistance Act and a statewide drug therapy
protocol pursuant to a collaborative pharmacy practice agreement.

House SponsorsJ. Ginal (D)
J. Becker (R)
Senate SponsorsI. Aguilar (D)
K. Priola (R)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeHealth and Human Services
StatusGovernor Signed (06/06/2018)
LobbyistsLobbyists
Category

Bill: HB18-1321
Title: Efficient Administration Medicaid Transportation
Position
Hearing Time
Hearing Room
CCW Summary Concerning efficient administration of nonemergency medical transportation within the existing benefit under the medical assistance program.

 

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (05/30/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsH. McKean (R)
J. Arndt (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (04/30/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/30/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill requires the department of health care policy and
financing (department) to create and implement a method for meeting
urgent transportation needs within the existing nonemergency medical
transportation benefit under the medical assistance program.
The method created by the department must provide medical

service provider and facility access to approved providers who can meet
urgent transportation needs, and include an efficient method for obtaining
and paying for the transportation services.

House SponsorsH. McKean (R)
J. Arndt (D)
Senate SponsorsD. Moreno (D)
B. Martinez Humenik (R)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeState, Veterans, and Military Affairs
StatusGovernor Signed (05/30/2018)
LobbyistsLobbyists
Category

Bill: HB18-1330
Title: Supplemental Payment Office-administered Drugs Medicaid
Position
Hearing Time
Hearing Room
CCW Summary

Concerning a supplemental state payment relating to certain office-administered oncology-related drugs for qualified providers under the medical assistance program who experienced a reduction in reimbursement payments in the 2017-18 state fiscal year as a result of the implementation of the federal final rules for covered outpatient drugs, and, in connection therewith, making an appropriation.

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (04/23/2018)
Senate CommitteeAppropriations
House SponsorsD. Young (D)
House CommitteeAppropriations
Hearing Date
Fiscal NotesFiscal Notes (03/26/2018)
Hearing Date
Fiscal NotesFiscal Notes (03/26/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

Joint Budget Committee. The bill authorizes a supplemental
payment of state-only money to providers under the medicaid program of
certain office-administered drugs relating to oncology who experienced
a decrease in aggregate reimbursements in the 2017-18 fiscal year as a
result of the implementation of the federal department of health and
human services final rule for covered outpatient drugs, 81 FR 5169,
published in the federal register on February 1, 2016.
The bill directs the department of health care policy and financing
(department) to distribute a supplemental payment to qualified providers,
as defined in the bill, and includes provisions for determining the amount
of each qualified provider's supplemental payment. The bill authorizes the
medical services board to adopt rules as necessary.
The bill appropriates general fund money to the department for the
supplemental payment to qualified providers.

House SponsorsD. Young (D)
Senate SponsorsD. Moreno (D)
House CommitteeAppropriations
Senate CommitteeAppropriations
StatusGovernor Signed (04/23/2018)
LobbyistsLobbyists
Category

Bill: HB18-1358
Title: Health Care Charges Billing Required Disclosures
Position
Hearing Time
Hearing Room
CCW Summary

Concerning required disclosures pertaining to charges for health care.

Bill Subject- Health Care & Health Insurance
- Insurance
StatusHouse Committee on Health, Insurance, & Environment Postpone Indefinitely (04/27/2018)
Senate Committee
House SponsorsM. Foote (D)
S. Beckman (R)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (04/23/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/23/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill imposes requirements on health care facilities, health care
providers, pharmacies, and health insurers, starting January 1, 2019, to
disclose information about health care charges. Specifically, section 2 of
the bill enacts the Comprehensive Health Care Billing Transparency
Act (act), which requires health care facilities, including hospitals,
ambulatory surgical centers, community clinics, and physician practice

groups, to:
  • Publish their fee schedules or other lists of charges the
facilities bill for specific health care services before
applying any discounts, rebates, or other charge adjustment
mechanisms;
  • Include in every bill sent to a patient an itemized detail of
each health care service provided, the charge for the
service, how any payment or adjustment by the patient's
health insurer was applied to each line item in the bill, and,
for hospitals, the amount of the healthcare affordability and
sustainability fee the hospital is charged; and
  • In situations where an individual provides health insurance
information to the facility or a provider in a facility setting,
disclose whether the facility or provider participates in the
individual's health insurance plan; whether the services the
facility or provider will render will be covered as an
in-network or out-of-network benefit; and whether the
individual will receive a service from an out-of-network
provider at an in-network facility.
For an individual health care provider who provides health care
services at a health care facility, has a separate fee schedule for the
services the provider delivers in the facility setting, and whose fees for
those services are not included in the facility's published fee schedule, the
provider must provide a fee schedule to the facility for posting on the
facility's website.
Section 2 also prohibits a facility or provider from billing a patient
or third-party payer an amount in excess of the lower of any established
self-pay rate or the lowest rate negotiated with or reimbursed by any
third-party payer, including the federal centers for medicare and medicaid
services in the United States department of health and human services, for
the particular health care services rendered to the patient if the facility or
provider has failed to publish or provide its fee schedule.
Additionally, section 2 requires a pharmacy to publish a list of its
retail drug prices, which is a list of the charges the pharmacy charges to
an insured or uninsured person for prescription drugs it administers or
dispenses, before any rebates, discounts, or other price adjustment
mechanisms are applied. Section 4 specifies that failure to comply with
the requirements to publish retail drug prices constitutes grounds for the
state board of pharmacy to discipline a pharmacist.
Health insurers, facilities, and providers are prohibited from
including any provision in a contract between the parties issued,
amended, or renewed on or after January 1, 2019, that restricts the ability
of a provider, facility, or health insurer to provide patients with the charge
information required to be published. Section 2 also directs the state
board of pharmacy to adopt rules necessary to implement the provisions
of the act that are applicable to pharmacies and the executive director of
the department of public health and environment to adopt any other rules
necessary to implement and administer the act.
Section 3 requires health insurers to publish information about
contract terms, cost-sharing arrangements, and prescription drug prices.
The commissioner of insurance is directed to adopt rules to implement
and administer these requirements and is authorized to use enforcement
powers under current law to enforce the requirements on health insurers.

House SponsorsM. Foote (D)
S. Beckman (R)
Senate SponsorsK. Lundberg (R)
I. Aguilar (D)
House CommitteeHealth, Insurance, & Environment
Senate Committee
StatusHouse Committee on Health, Insurance, & Environment Postpone Indefinitely (04/27/2018)
LobbyistsLobbyists
Category

Bill: HB18-1370
Title: Drug Coverage Health Plan
Position
Hearing Time
Hearing Room
CCW Summary

Concerning a prohibition against excluding a drug from a health coverage plan if the drug was approved by the plan for coverage of the covered person at the time the covered person enrolled in the plan.

Bill Subject- Health Care & Health Insurance
- Insurance
StatusHouse Committee on Health, Insurance, & Environment Postpone Indefinitely (05/03/2018)
Senate Committee
House SponsorsJ. Singer (D)
D. Esgar (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (04/18/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/18/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill prohibits a health insurance carrier from excluding or
limiting a drug under a health benefit plan and from moving the drug to
a disadvantaged tier in the plan formulary if the drug was covered at the

time the covered person enrolled in the plan. A carrier may not increase
the amount that a covered person pays for a copayment, coinsurance, or
deductible or set limits while the covered person is covered by the health
benefit plan for drugs that were covered when the person became covered
under the plan.
If a carrier uses a tiered plan, the carrier may not move a drug to
a disadvantaged tier under specified circumstances.
A carrier may limit coverage for a drug or biosimilar product if a
provider prescribes a generic drug or biosimilar product to treat the
covered person's medical condition instead of the originally-prescribed
drug and the covered person agrees.

House SponsorsJ. Singer (D)
D. Esgar (D)
Senate SponsorsC. Jahn (D)
House CommitteeHealth, Insurance, & Environment
Senate Committee
StatusHouse Committee on Health, Insurance, & Environment Postpone Indefinitely (05/03/2018)
LobbyistsLobbyists
Category

Bill: HB18-1431
Title: Statewide Managed Care System
Position
Hearing Time
Hearing Room
CCW Summary

Concerning updating managed care provisions in the medical assistance program, and, in connection therewith, aligning managed care provisions with new federal managed care regulations, removing obsolete or duplicative statutory language and programs, and updating and aligning statutory provisions to reflect the current statewide managed care system.

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (05/29/2018)
Senate CommitteeFinance
House SponsorsJ. Ginal (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (04/30/2018)
Hearing Date
Fiscal NotesFiscal Notes (04/30/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary


The bill amends, repeals, and relocates provisions of part 4 of
article 5 of title 25.5, Colorado Revised Statutes, relating to managed care
provisions under the medical assistance program to align with the federal
Medicaid and CHIP Managed Care Final Rule of 2016, and to reflect
the implementation of the accountable care collaborative as the statewide
managed care system.
The bill:
  • Updates the definition of the statewide managed care
system and makes conforming amendments throughout the
statutes;
  • Integrates medicaid community mental health services into
the statewide managed care system;
  • Includes capitated rates specifically for community mental
health services;
  • Establishes the medical home model of care for the
statewide managed care system;
  • Relocates provisions relating to graduate medical
education;
  • Clarifies that the statewide managed care system is
authorized to provide services under a single managed care
entity (MCE) or a combination of MCE types, including
primary care case management entities authorized under
federal law;
  • Removes duplicate provisions relating to the medicaid
reform and innovation pilot program;
  • Relocates provisions relating to the requirement that MCEs
certify capitation payments as sufficient;
  • Removes outdated language referencing behavioral health
organizations;
  • Updates the definitions for managed care and managed
care entities and adds definitions for medical home and
primary care case management entities;
  • Aligns provisions in statutes relating to the features of
MCEs with new and existing federal managed care
regulations that require:
  • Criteria for accepting enrollees and protecting
enrollees from discrimination;
  • Provisions relating to network adequacy standards;
  • Revised communication standards;
  • Updated provisions relating to grievances and
appeals;
  • Participation in a comprehensive quality assessment
and performance improvement program; and
  • Administration of a program integrity system;
  • Removes certain provisions from statute relating to
prescription drug contracting practices that were relevant
to a competitive managed care organization model or that
duplicated provisions established in rule;
  • Removes references to the obsolete primary care physician
program;
  • Increases the timeline for the rate setting process for
capitation rates to meet new federal review requirements;
  • Repeals statutory sections that contain provisions that are
relocated or revised and included in other statutory sections
in the bill, and repeals statutory sections that include
obsolete programs or policies; and
  • Updates statutory references to reflect the relocated,
revised, or repealed provisions.

House SponsorsJ. Ginal (D)
Senate SponsorsJ. Smallwood (R)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeFinance
StatusGovernor Signed (05/29/2018)
LobbyistsLobbyists
Category

Bill: HB18-1438
Title: Health Care Coverage Reproductive Health Care
Position
Hearing Time
Hearing Room
CCW Summary

Concerning eliminating the requirement that a person who participates in college-level academic programs through the correctional education program in the department of corrections must bear entirely the costs associated with such programs.

Bill Subject- Health Care & Health Insurance
- Insurance
- Public Health
StatusHouse Committee on Health, Insurance, & Environment Postpone Indefinitely (05/03/2018)
Senate Committee
House SponsorsD. Esgar (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (05/03/2018)
Hearing Date
Fiscal NotesFiscal Notes (05/03/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

Section 2 of the bill requires all individual and group health
benefit plans issued, amended, or renewed on or after January 1, 2020, to
provide coverage for specified reproductive health care services, drugs,
devices, products, and procedures. Carriers are prohibited from imposing
a deductible, coinsurance, copayment, or other cost-sharing requirement
for the coverage required under the bill and from imposing restrictions or

delays on the coverage. Under specified circumstances, section 2 permits
a carrier to offer a religious employer a plan that does not include
coverage for abortion procedures that are contrary to the religious
employer's religious tenets. Section 2 also prohibits a carrier from
excluding an individual from participation in, denying an individual
benefits under, or otherwise discriminating against an individual in the
administration of a plan on the basis of the individual's actual or
perceived race, color, national origin, sex, sexual orientation, gender
identity, religion, age, or disability.
Section 4 directs the department of health care policy and
financing to administer a program to reimburse the cost of specified
reproductive health care services, drugs, devices, products, and
procedures provided to eligible individuals, which is defined to include
individuals with reproductive health care needs who are enrolled in the
medicaid program or the children's basic health plan or who are otherwise
disqualified for participation in the medicaid program based on their
immigration status.
The program must also provide medicaid or children's basic health
plan benefits, as applicable, to pregnant individuals for 180 days, rather
than the mandated 60 days, post-pregnancy, regardless of whether the
individual's medicaid or children's basic health plan eligibility would
otherwise terminate during that period based on an increase in income.

House SponsorsD. Esgar (D)
Senate Sponsors
House CommitteeHealth, Insurance, & Environment
Senate Committee
StatusHouse Committee on Health, Insurance, & Environment Postpone Indefinitely (05/03/2018)
LobbyistsLobbyists
Category

Bill: SB18-022
Title: Clinical Practice For Opioid Prescribing
Position
Hearing Time
Hearing Room
CCW Summary

Concerning clinical practice measures for safer opioid prescribing.

Bill Subject- Health Care & Health Insurance
StatusGovernor Signed (05/21/2018)
Senate CommitteeHealth and Human Services
House SponsorsB. Pettersen (D)
C. Kennedy (D)
House CommitteeHealth, Insurance, & Environment
Hearing Date
Fiscal NotesFiscal Notes (03/21/2018)
Hearing Date
Fiscal NotesFiscal Notes (03/21/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

Opioid and Other Substance Use Disorders Interim Study
Committee. The bill restricts the number of opioid pills that a health care
practitioner, including physicians, physician assistants, advanced practice
nurses, dentists, optometrists, podiatrists, and veterinarians, may prescribe
for an initial prescription to a 7-day supply and one refill for a 7-day
supply, with certain exceptions. The bill clarifies that a health care

practitioner may electronically prescribe opioids.
Current law allows health care practitioners and other individuals
to query the prescription drug monitoring program (program). The bill
requires health care practitioners to query the program before prescribing
the first refill prescription for an opioid except under specified
circumstances, and requires the practitioner to indicate his or her specialty
or practice area upon the initial query.
The bill requires the department of public health and environment
to report to the general assembly its results from studies regarding the
prescription drug monitoring program integration methods and health care
provider report cards.

House SponsorsB. Pettersen (D)
C. Kennedy (D)
Senate SponsorsI. Aguilar (D)
J. Tate (R)
House CommitteeHealth, Insurance, & Environment
Senate CommitteeHealth and Human Services
StatusGovernor Signed (05/21/2018)
LobbyistsLobbyists
Category

Bill: SB18-023
Title: Promote Off-label Use Pharmaceutical Products
Position
Hearing Time
Hearing Room
CCW Summary

Concerning the promotion of the off-label use of pharmaceutical products.

Bill Subject- Health Care & Health Insurance
StatusSenate Committee on Health & Human Services Postpone Indefinitely (02/15/2018)
Senate CommitteeHealth and Human Services
House SponsorsJ. Ginal (D)
House Committee
Hearing Date
Fiscal NotesFiscal Notes (01/19/2018)
Hearing Date
Fiscal NotesFiscal Notes (01/19/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill allows a pharmaceutical manufacturer or its representative
to promote the off-label use of a prescription drug, biological product, or
device approved by the United States food and drug administration.

House SponsorsJ. Ginal (D)
Senate SponsorsB. Martinez Humenik (R)
House Committee
Senate CommitteeHealth and Human Services
StatusSenate Committee on Health & Human Services Postpone Indefinitely (02/15/2018)
LobbyistsLobbyists
Category

Bill: SB18-024
Title: Expand Access Behavioral Health Care Providers
Position
Hearing Time
Hearing Room
CCW Summary

Concerning modifications to the Colorado health service corps program administered by the department of public health and environment to expand the availability of behavioral health care providers in shortage areas in the state.

Bill Subject- Health Care & Health Insurance
- Labor & Employment
StatusGovernor Signed (05/21/2018)
Senate CommitteeHealth and Human Services
House SponsorsJ. Singer (D)
B. Pettersen (D)
House CommitteePublic Health Care and Human Services
Hearing Date
Fiscal NotesFiscal Notes (06/21/2018)
Hearing Date
Fiscal NotesFiscal Notes (06/21/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

Opioid and Other Substance Use Disorders Interim Study
Committee. The bill modifies the Colorado health service corps program

administered by the primary care office in the department of public health
and environment as follows:
  • For purposes of determining areas in the state in which
there is a shortage of health care professionals and
behavioral health care providers to meet the needs of the
community, allows the primary care office, under guidance
adopted by the state board of health, to develop and
administer state health professional shortage areas using
state-specific methodologies;
  • Allows behavioral health care providers, which include
licensed and certified addiction counselors, licensed
professional counselors, licensed clinical social workers,
licensed marriage and family therapists, clinical
psychologists, advanced practice nurses, and physicians
certified or trained in addiction medicine, pain
management, or psychiatry, and candidates for licensure as
an addiction counselor, professional counselor, clinical
social worker, marriage and family therapist, or
psychologist, to participate in the loan repayment program
on the condition of committing to provide behavioral health
care services in health professional shortage areas for a
specified period;
  • Directs the advisory council to prioritize loan repayment
and scholarships for those behavioral health care providers,
candidates for licensure, or addiction counselors who
provide behavioral health care services in nonprofit or
public employer settings but permits consideration of
applicants practicing in a private setting that serves
underserved populations;
  • Establishes a scholarship program to help defray the
education and training costs associated with obtaining
certification as an addiction counselor or with progressing
to a higher level of certification;
  • Adds 2 members to the advisory council that reviews
program applications, which members include a
representative of an organization representing substance
use disorder treatment providers and a licensed or certified
addiction counselor who has experience in rural health,
safety net clinics, or health equity;
  • Modifies program reporting requirements and requires
annual reporting that coincides with required SMART Act
reporting by the department; and
  • Requires the general assembly to annually appropriate $2.5
million from the marijuana tax cash fund to the primary
care office to provide loan repayment for behavioral health
care providers and candidates for licensure participating in
the Colorado health service corps and to award
scholarships to addiction counselors participating in the
scholarship program.

House SponsorsJ. Singer (D)
B. Pettersen (D)
Senate SponsorsC. Jahn (D)
J. Tate (R)
House CommitteePublic Health Care and Human Services
Senate CommitteeHealth and Human Services
StatusGovernor Signed (05/21/2018)
LobbyistsLobbyists
Category

Bill: SB18-065
Title: Add Health Maintenance Organizations Life And Health Insurance Protection Association
Position
Hearing Time
Hearing Room
CCW Summary

Concerning modifications to the 'Life and Health Insurance Protection Association Act'.

Bill Subject- Health Care & Health Insurance
- Insurance
StatusSenate Committee on Business, Labor, & Technology Postpone Indefinitely (02/16/2018)
Senate CommitteeBusiness, Labor and Technology
House SponsorsT. Kraft-Tharp (D)
House Committee
Hearing Date
Fiscal NotesFiscal Notes (01/24/2018)
Hearing Date
Fiscal NotesFiscal Notes (01/24/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill amends the Life and Health Insurance Protection
Association Act as follows:
  • Adds health maintenance organizations (HMOs) as
members of the association and subjects HMOs to
assessments from the association;
  • Allocates responsibility for long-term care insurance

assessments between health insurance and life insurance
association members; and
  • Requires member insurers that write health benefit plans in
Colorado to collect a fee of up to $2 per month from each
certificate holder, policyholder, or contract holder for each
certificate, policy, or contract the member insurer issues, to
be deposited into a fund for the purpose of defraying the
costs of a health insurer insolvency.

House SponsorsT. Kraft-Tharp (D)
Senate SponsorsR. Gardner (R)
House Committee
Senate CommitteeBusiness, Labor and Technology
StatusSenate Committee on Business, Labor, & Technology Postpone Indefinitely (02/16/2018)
LobbyistsLobbyists
Category

Bill: SB18-080
Title: Wholesale Canadian Drug Importation Program
Position
Hearing Time
Hearing Room
CCW Summary

Concerning wholesale importation of pharmaceuticals from Canada for resale to Colorado residents.

Bill Subject- Health Care & Health Insurance
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (02/05/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsS. Lontine (D)
House Committee
Hearing Date
Fiscal NotesFiscal Notes (01/30/2018)
Hearing Date
Fiscal NotesFiscal Notes (01/30/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill creates the Colorado Wholesale Importation of
Prescription Drugs Act, under which the department of health care
policy and financing (department) must design a program to import
prescription pharmaceuticals from Canada for sale to Colorado
consumers. The program design must ensure both drug safety and cost
savings for Colorado consumers. The department must submit the

program design to the secretary of the United States department of health
and human services and request the secretary's approval of the program
as meeting the requirements of federal law to import Canadian
pharmaceutical products.
If the secretary approves the program, the department must
implement the program. The department must adopt a funding mechanism
to cover the program's administrative costs, and the department must
annually report on the program to the general assembly.

House SponsorsS. Lontine (D)
Senate SponsorsI. Aguilar (D)
House Committee
Senate CommitteeState, Veterans, and Military Affairs
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (02/05/2018)
LobbyistsLobbyists
Category

Bill: SB18-081
Title: Emergency Medical Service Providers Licensing
Position
Hearing Time
Hearing Room
CCW Summary

Concerning emergency medical service provider licensure, and, in connection therewith, changing references from emergency medical service provider certification to emergency medical service provider licensure and requiring license applicants to make certain disclosures to the director of the division of professions and occupations in the department of regulatory agencies at the time of application.

Bill Subject- Health Care & Health Insurance
StatusSenate Committee on Business, Labor, & Technology Postpone Indefinitely (01/24/2018)
Senate CommitteeBusiness, Labor and Technology
House Sponsors
House Committee
Hearing Date
Fiscal NotesFiscal Notes (01/23/2018)
Hearing Date
Fiscal NotesFiscal Notes (01/23/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

Currently, regulation of an emergency medical service provider,
including a paramedic, is referred to as certification. Section 1 of the bill
changes certification references to licensure.
Section 2 requires an emergency medical service provider
applying for a new license or renewing, reinstating, or reactivating a
license to comply with the Michael Skilnik Medical Transparency Act
of 2010.
Sections 3 to 29 make conforming amendments.

House Sponsors
Senate SponsorsL. Garcia (D)
House Committee
Senate CommitteeBusiness, Labor and Technology
StatusSenate Committee on Business, Labor, & Technology Postpone Indefinitely (01/24/2018)
LobbyistsLobbyists
Category

Bill: SB18-129
Title: Reorganize Drugs & Medical Devices Sales Tax Exemption
Position
Hearing Time
Hearing Room
CCW Summary

Concerning the nonsubstantive reorganization of the law exempting from state sales tax certain drugs and medical and therapeutic devices.

Bill Subject- Fiscal Policy & Taxes
StatusGovernor Signed (04/12/2018)
Senate CommitteeHealth and Human Services
House SponsorsJ. Arndt (D)
House CommitteeFinance
Hearing Date
Fiscal NotesFiscal Notes (02/06/2018)
Hearing Date
Fiscal NotesFiscal Notes (02/06/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

Statutory Revision Committee. In order to increase
comprehensibility of the law exempting from state sales tax certain drugs
and medical and therapeutic devices, the bill:
  • Condenses the 5 essentially identical definitions of the term
prescription in the current law into a single definition;

  • Relocates another defined term within that law so that all
definitions are in the same place, which relocation
necessitates relettering existing defined terms so as to
maintain alphabetical order; and
  • Makes other adjustments to the current language by
removing the false imperative, removing superfluous
verbiage, and updating internal citations to conform to
modern drafting format.

House SponsorsJ. Arndt (D)
Senate SponsorsD. Moreno (D)
House CommitteeFinance
Senate CommitteeHealth and Human Services
StatusGovernor Signed (04/12/2018)
LobbyistsLobbyists
Category

Bill: SB18-152
Title: Prohibit Price Gouging On Prescription Drugs
Position
Hearing Time
Hearing Room
CCW Summary

Concerning a prohibition against price gouging on certain prescription drugs.

Bill Subject- Health Care & Health Insurance
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (02/14/2018)
Senate CommitteeState, Veterans, and Military Affairs
House SponsorsS. Lontine (D)
House Committee
Hearing Date
Fiscal NotesFiscal Notes (02/13/2018)
Hearing Date
Fiscal NotesFiscal Notes (02/13/2018)
Full TextFull Text of Bill
Category
Comment
Custom Summary
Official Summary

The bill:
  • Prohibits a pharmaceutical manufacturer or wholesaler
from price gouging on sales of essential off-patent or
generic drugs;
  • Makes the practice of price gouging a deceptive trade
practice under the Colorado Consumer Protection Act;

and
  • Requires the state board of pharmacy and the executive
director of the department of health care policy and
financing to report suspected price gouging to the attorney
general. The attorney general is authorized to seek
subpoenas and file lawsuits with the appropriate district
courts.

House SponsorsS. Lontine (D)
Senate SponsorsI. Aguilar (D)
House Committee
Senate CommitteeState, Veterans, and Military Affairs
StatusSenate Committee on State, Veterans, & Military Affairs Postpone Indefinitely (02/14/2018)
LobbyistsLobbyists
Category

back to top
 
border   border
 
Copyright © 2018 State Capitol Watch